Aleafia Health Successfully Completes TSX Review and Announces Entry into Fifth Province
Successful completion of TSX listing review Expansion of adult-use portfolio into key fifth province 5…
Year: 2022
Bitbuy Announces the Appointment of Jeff Fitzgerald as Vice President of Sales, Private Wealth and Corporate Solutions
Vancouver, British Columbia–(Newsfile Corp. – November 28, 2022) – WonderFi Technologies Inc. (TSX: WNDR)Â (OTCQB: WONDF)…
Truvid Collaborates with Omri Hurwitz Media to Expand their User-Generated Library with Premium Tech Content
Tel Aviv, Israel–(Newsfile Corp. – November 28, 2022) – Truvid, a forward-thinking video-exchange technology, collaborates…
Coloured Ties Amends C$3,375,000 Substantial Issuer Bid
Vancouver, British Columbia–(Newsfile Corp. – November 28, 2022) – Coloured Ties Capital Inc. (TSXV: TIE)Â (“CTI”…
Yalla Group Q3 Earnings: Quarterly revenue passes US$ 80 million as steady growth continues
HONG KONG, Nov 28, 2022 – (ACN Newswire) – On November 15, 2022, Yalla (NYSE:…
Sunstone Management Names Zhen Wang as Founder Community Manager
New addition to spearhead efforts providing startup founders with necessary resources to reach development goals…
Digital Air Strike Launches Thought Leadership Training to Give Competitive Edge to Business Clients
Leading CX technology company providing Limitless Minds training founded by Russell Wilson and Harry Wilson,…
ComEd Explores Battery Energy Storage to Improve Resiliency for Customers in Northern Illinois
Technology demonstration focused on select rural customers that have experienced challenging outages in recent years…
Autonomy Year-End Sale Guarantees Lowest Price Anywhere for Tesla Model 3
SANTA MONICA, Calif.–(BUSINESS WIRE)–Autonomy™, the nation’s largest electric vehicle subscription company, today announced special year-end…
Innovation Pharmaceuticals Announces BT BeaMedical Technologies Receives FDA Clearance for New Surgical Laser Family
Regulatory clearance lays key technological and regulatory foundation for BT BeaMedical’s vision of revolutionizing treatment…
Panbela Announces First Patients Enrolled in Europe for ASPIRE Trial Studying Ivospemin (SBP-101) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
MINNEAPOLIS, Nov. 28, 2022 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc . (Nasdaq: PBLA), a clinical stage…
Tenaya Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for its Gene Therapy for Genetic Arrhythmogenic Right Ventricular Cardiomyopathy
TN-401 is being developed for the treatment of genetic arrhythmogenic right ventricular cardiomyopathy (ARVC) caused…
*FINAL REMINDER* AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 *FINAL REMINDER*
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
Veru to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results on December 5, 2022
MIAMI, Nov. 28, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused…
ContraFect Announces ANSM Approval of Clinical Trial Application for Exebacase in Prosthetic Joint Infections
YONKERS, N.Y., Nov. 28, 2022 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology…
Providence Therapeutics Presents Phase 2 Data on its mRNA COVID-19 Vaccine Candidate PTX-COVID19-B at the 2022 World Vaccine & Immunotherapy Congress
Presentation highlights data from PRO-CL-002 Phase 2 study of Providence’s mRNA COVID-19 vaccine candidate, PTX-COVID19-B…
Study Showing Significant Improvements in Itch and Itch-Related Sleep Loss with Roflumilast Cream in Adults with Plaque Psoriasis Published in American Journal of Clinical Dermatology
Newly published phase 2b trial data show those treated with roflumilast cream had significantly greater…
Cidara Therapeutics and Melinta Therapeutics Announce Publication of Data from the Global Phase 3 Pivotal ReSTORE Trial of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis in The Lancet
Publication details the efficacy and safety of rezafungin dosed once-weekly versus the current of care…
Praxis Precision Medicines to Advance PRAX-562 Phase 2 Study in Pediatric Patients with Developmental and Epileptic Encephalopathies
BOSTON, Nov. 28, 2022 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
Selecta Biosciences Announces Appointment of Blaine Davis as Chief Financial Officer
WATERTOWN, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology…